SILO (Silo Pharma, Inc. Common Stock) Stock Analysis - AI Report

Silo Pharma, Inc. Common Stock (SILO) is a publicly traded Healthcare sector company. As of May 21, 2026, SILO trades at $0.37 with a market cap of $6.31M and a P/E ratio of -0.76. SILO moved -0.13% today. Year to date, SILO is +5.20%; over the trailing twelve months it is -23.78%. Its 52-week range spans $0.22 to $3.37. Rallies surfaces SILO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on SILO?

Rallies AI research for SILO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

SILO Key Metrics

Key financial metrics for SILO
MetricValue
Price$0.37
Market Cap$6.31M
P/E Ratio-0.76
EPS$-0.50
Dividend Yield0.00%
52-Week High$3.37
52-Week Low$0.22
Volume0
Avg Volume0
Revenue (TTM)$72.10K
Net Income$-4.23M
Gross Margin38.57%

Latest SILO News

Recent SILO Insider Trades

  • Weisblum Eric bought 2.50K (~$1.02K) on Dec 15, 2025.
  • Weisblum Eric bought 2.50K (~$1.05K) on Dec 15, 2025.
  • Weisblum Eric bought 1.00K (~$365) on Nov 21, 2025.

SILO Analyst Consensus

SILO analyst coverage data. Average price target: $0.00.

Common questions about SILO

What is the AI research view on SILO?
Rallies AI research for SILO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for SILO?
Rallies AI research for SILO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is SILO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SILO. It does not provide personalized investment advice.
SILO

SILO